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Assessment of a supported discharge service for a cohort of patients admitted to Cork University 
Hospital with COVID-19 that were identified as being appropriate for remote patient monitoring. 
 
Methods 
Patients uploaded SpO2, subjective breathlessness scores, and temperature readings onto the 
PatientMpower application, and received a daily phone call from the physiotherapist. Readmission 




Over 12 weeks, 15 patients had a supported discharge. Readmission was triggered for 3 patients (20%). 
Compared to non-readmitted patient, readmitted patients had more abnormal SpO2 readings (9 (5.5-
22.5) vs 1 (0-1), p= 0.022) and all 6 temperature spikes that occurred, but lower subjective 
breathlessness scores (3 (1-6) vs 4.25 (2-8), p = 0.003). Differences in mean abnormal SpO2% readings 
were not statistically significant. 
 
Conclusion 
A supported discharge service including remote monitoring and regular contact with healthcare 






COVID-19 is an illness caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus-
2 (SARS-CoV-2, 2019-nCoV). Hospitalisation rates currently range from 1% -18% depending on age and 
comorbidities, with an average length of inpatient stay of 11 days1,2. We implemented protocols to 
facilitate COVID-19 supported discharge, utilising remote patient monitoring and a virtual early 






Over a 12-week period from May to July 2020, 28 patients admitted to Cork University Hospital (CUH) 
with Covid-19 were found to be suitable for a supported discharge, and fifteen of these expressed 
interest in taking part. Inclusion criteria included stable medical condition, and oxygen saturations 
(SpO2) >92% on room air, while access to a smartphone was desirable. Training was given on using the 
Nonin 3230 Bluetooth® Smart-Pulse device to check SpO2 4 times per day, which was uploaded 
together with an oral temperature reading and a subjective breathlessness score to the 
“PatientMpower for COVID -19” mobile application3. Data was reviewed by a respiratory 
physiotherapist who gave a daily wellbeing phone call for at least 14 days post discharge with advice 
such as active cycle of breathing and diaphragmatic breathing techniques. SpO2 readings ≤92%, 
temperature ≥38.3 °C and increasing breathlessness scores necessitated review, and the need for 
readmission was triggered following assessment by the primary medical team. Patient satisfaction 
questionnaires were completed upon service discharge. Data was collected in line with GDPR 





The characteristics of the cohort and the relevant p-values are shown in Table 1. Three patients were 
readmitted by their respective medical teams. These patients accounted for 81.0% of the 58 abnormal 
SpO2 readings that were found to be outside of the parameters accepted by this study, and 31.4% of 
the total 385 data reviews. The median length of initial hospitalisation was also higher in readmitted 
patients than those not readmitted at 31 (30.5-35) and 5.5 (3-16.5) days respectively. 
 
The median number of abnormal SpO2 readings was 9 (5.5-22.5) and 1 (0-1) in the re-admitted and 
non-readmitted patients respectively (Mood’s median test, p = 0.022), while the differences in mean 
abnormal SpO2% readings were not found to be statistically significant (T-test, p = 0.76).  
 
Only 7 patients (46.7%) entered a subjective breathlessness score. The mean breathlessness score of 
4.25 (2-8) was higher in the non-readmitted patients than that of the readmitted patient at 3 (1-6), (T-
test, p = 0.003). All of the reported temperature spikes occurred in readmitted patients (n=6). 
 
In total, 176 phone calls were made by the respiratory physiotherapists, with 13 and 9 direct 
communications made to the primary medical teams of readmitted patients and non-readmitted 
respectively.  
 
Ten patients responded to a follow up questionnaire. All 10 respondents rated the receipt of a daily 
well-being call as the most helpful aspect of the service, and that they were happy with the level of 
support they received from the service while at home. Eight patients (80%) reported a preference for 
home monitoring and 9 patients (90%) found the mobile application and pulse oximeter easy to use. 
 
 
 All cohort (n=15) Readmitted (n=3) No readmission (n=12) 
Mean age 58 (42.5-62.5) 59 (52-61) 57.5 (38.25-62.5) 
Male 12 3 9 
Female 3 0 3 
Median length of initial hospital 
stay 
6 (3.5-18) 31 (30.5-35) 5.5 (3-16.5) 
Median length of home 
monitoring 
16 (12.5-32.5) 31 (30.5-35) 15 (11.75-20.5) 
Median length of readmission 
stay 
N/A 8 (1.75-16.75) N/A 
Median number of days from 
discharge to re-admission 
N/A 8 (5-13.5) N/A 
Mean number of SpO2 inputs 
per day 
4.6 4.6 4.6 
Mean SpO2 outside of 
parameters (SpO2 %) (T-test, p = 
0.76) 
91.2 (80-92) 91.2 (80-92) 91.25 (89-92) 
Total number of SpO2 inputs 
outside of parameters 
58 47 (81.0%) 11 (19.0%) 
Median number of SpO2 inputs 
outside of parameters (Mood’s 
median test, p = 0.022) 
1 (0-2) 9 (5.5-22.5) 1 (0-1) 
Number of patients that made a 
breathlessness score entry 
7 1 6 
Total number of breathlessness 
score entries 
288 61 (21.2%) 227 (78.8%) 
Mean breathlessness score 
(Score range of 1-10) (T-test, p = 
0.003) 
4 (1-8) 3 (1-6) 4.25 (2-8) 
Number of temperature spikes 
recorded (>38.3°C) 
6 6 0 
 
Table 1: Demographic information and clinical characteristics of the virtual monitoring 
All data presented in Table 1 is expressed as a mean value with ranges in parenthesis, a median with 
interquartile range in parenthesis or an absolute figure with a percentage of total in parenthesis. 
Abbreviations: SpO2 = Oxygen saturation, Mean breathlessness score = A higher score indicated a 
greater degree of breathlessness, a lower score indicated a lesser degree of breathlessness. Where 





The primary findings of this study were that patients with COVID-19 who required readmission had a 
greater number of abnormal SpO2 readings during virtual home monitoring than those who did not 
require readmission. The programme was received positively by the discharged patients and 
facilitated re-admission in those with clinical deterioration. In support of our findings a similar study 
remotely monitored oxygen saturations in patients with Covid-19 and concluded that their 
programme recognised “early recognition of acute deterioration” allowing for readmission where 
necessary4, while other studies in severe asthma and pulmonary fibrosis have found a positive role for 
telemedicine in patient general well-being5,6. 
 
Interestingly mean breathlessness scores were higher in the non-readmitted patients which may be in 
keeping with the ‘Happy Hypoxia’ phenomenon in Covid-19 patients7 and combined with the need to 
manually enter this score, explains why only 7 of the patients filled this section.  
 
Although a number of older patients had difficulty accessing a smart phone this did not result in 
exclusion and was resolved by recording the patient’s readings at the daily wellbeing phone call, 
however this may be an issue when replicating the programme in centres without these supports8. 
The decision against remote spirometry was made due to the potential for poor technique at home 
by a number of the patients. 
 
This pilot study demonstrates the utility of the CUH COVID Supported Discharge Programme in 
addition to the positive patient feedback regarding this mode of care. 
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